Brief: Oncolytics Biotech Presents Clinical Proof-Of-Concept Data In Multiple Myeloma At ASCO Virtual Annual Meeting
29/05/2020 12:48
May 29 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® PRESENTS CLINICAL PROOF-OF-CONCEPT
DATA IN
MULTIPLE MYELOMA AT THE ASCO VIRTUAL ANNUAL MEETING
Source text for Eikon: ID:nCNWd4nNJa
Further company coverage: ONC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer